Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
GenScript and Genopis Enter Into Strategic Partnership Agreement for Manufacture Service of GMP Plasmids 2020-01-16 01:00
WuXi Advanced Therapies Launches New World-Class AAV Vector Suspension Platform 2020-01-13 22:00
WuXi Biologics and Almirall Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases 2020-01-09 17:10
Transcenta Holding Secures $100 Million Series B Plus Financing 2020-01-08 21:00
Gracell Initiates Investigational Study of the Technological Breakthrough TruUCAR™ Therapy for Relapsed or Refractory T-cell Malignancies 2020-01-07 22:00
Beta Lifescience Announces the Online Availability of Quality Immune Checkpoint Proteins for Scientific Discoveries 2020-01-07 21:10
Transcenta to Present at the 38th Annual J.P. Morgan Healthcare Conference 2020-01-07 00:00
I-Mab Biopharma Announces Dosing of First Patient in a Pivotal Study of TJ202/MOR202 in Multiple Myeloma in Mainland China 2020-01-04 00:07
AgriTalk Integrates Biotechnology, Iot, Big Data Analysis, and Ai to Develop a Non-Toxic Agricultural Disease and Fertilizer Regulation System 2020-01-03 13:14
WuXi STA Opens Oligonucleotide Large-Scale Manufacturing Facility 2020-01-03 08:10
Gracell to Present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco 2019-12-30 23:09
GenScript and Selecxine Enter Into Strategic Cooperation Agreement 2019-12-26 22:00
Viva Biotech Awarded 'Top 10 Public Companies' 2019-12-24 18:18
China's Largest Plasmid and Virus Facility from GenScript was Put into Operation 2019-12-20 22:00
Bridge Biotherapeutics Files Investigational New Drug Application for BBT-176, an EGFR TKI for NSCLC 2019-12-20 10:19
TransThera Biosciences Announces IND Approval from FDA for Clinical Studies of TT-00920 to Treat Chronic Heart Failure 2019-12-17 08:00
Senhwa Biosciences Reports Positive Phase 1 Data of CX-5461 in Patients With Advanced Solid Tumors at 2019 SABCS 2019-12-13 04:00
Gracell Announces Progressive Outcomes from Multiple Human Clinical Trials to Investigate FasTCAR and Dual CAR Cell Platform Technologies 2019-12-09 22:00
BJ Bioscience Announces First Patient Dosed in FIH Trial of BJ-001 in Patients with Locally Advanced/Metastatic Solid Tumors 2019-12-09 21:00
CARsgen Therapeutics Receives IND Clearance from the NMPA for AB011 Humanized Claudin18.2 Monoclonal Antibody 2019-12-09 18:00
1 126 127 128 129 130 222